Uppsala, Sweden, November 27th, 2009
Beactica, the Swedish fragment-based drug discovery company, today announced its participation in a Marie Curie Initial Training Network (ITN). The ITN, called BrainTrain, is funded through the 7th EU Framework Programme and aims to deliver 15 skilled early stage researchers... [...]
Uppsala, Sweden, May 26th, 2009
Beactica AB, the Swedish fragment-based drug discovery company, today announced that it has entered into an agreement with Cubist Pharmaceuticals, Inc. (Lexington, MA; NASDAQ: CBST). Under the agreement, Beactica will use its surface plasmon resonance (SPR)-integrated drug... [...]
Uppsala, Sweden, January 13th, 2009
Beactica AB, the Swedish fragment-based drug discovery company, today announced a new research collaboration agreement with GE Healthcare (Chalfont St. Giles, UK), the world leading provider of molecular interaction analysis tools, and Uppsala University (Sweden). The collaboration... [...]
Uppsala, Sweden, August 15th, 2008
Beactica AB, a fragment-based drug discovery company spun out of Uppsala University, today announced a new investment and the addition of Uppsala University Holding Company to its shareholders. The funding will support Beactica’s growing internal drug discovery pipeline.
Uppsala, Sweden, April 24th, 2008
Two leading companies in the area of fragment-based drug discovery (FBDD) today announced a new commercial alliance. IOTA Pharmaceuticals Ltd, based in Cambridge, UK, and Beactica AB, based in Uppsala, Sweden, will join forces to deploy a proprietary FBDD-based lead discovery and... [...]
Uppsala, Sweden, November 12th, 2007
Beactica AB announced today that it has entered into a drug discovery collaboration agreement with Arrow Therapeutics Ltd (London, UK) whereby Beactica will direct its novel characterisation technology at selected Arrow compounds against a confidential target.
"We are... [...]
Uppsala, Sweden, November 1st, 2007
Beactica, the specialist drug discovery company spun out of Uppsala University in 2006, announced today that it has moved into new premises at the Uppsala Biomedical Centre.
"The move reflects a growing demand for Beactica’s partnership programme from other drug discovery... [...]
Uppsala, Sweden – September 14th, 2007
Beactica, the specialist drug discovery company spun out of Uppsala University in 2006, will partner in two separate projects both of which have been selected for major grants through the 7th EU Framework Programme. In each project Beactica will apply its drug discovery platform... [...]
Sweden, June 7, 2007
Beactica receives continued funding from Innovationsbron Uppsala to develop its business. [...]
Sweden, April 2, 2007
Beactica receives funding from the Swedish Governmental Agency for Innovation Systems (VINNOVA) to establish a European drug discovery project. [...]